Artelo Biosciences, Inc. (ARTL) Misses Q1 EPS by 59c
Tweet
Share
E-mailGet Alerts ARTL Hot Sheet
Join SI Premium – FREE
Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q1 EPS of ($0.72), $0.59 worse than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- GrafTech to permanently close Monterrey graphite electrode plant
- Ophir Metals names Eric Tsung as new CFO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
